PATENT CLAIM ANALYSIS

Application Number: 16021543
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-05
Patent Classification: ["424", "204100"]

Abstract:
The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.

Claim (Index 4):
The vector of  claim 3 , wherein said nucleic acid sequence comprises the sequence of SEQ ID NO: 24.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.21739
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15358288', '14281287', '13396298', '13396318', '11459542']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7264071561954196
- 35 USC 102 Novelty (BERT): 0.5796503358750267
- Combined Prediction Score: 0.7117314741633803
- Mean Citation Score: 505.985274
- Max Citation Score: 613.8808
- Similarity Product: 342.22691326045987

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test